Literature DB >> 20066417

Stenting of the superior mesenteric vein in midgut carcinoid disease with large mesenteric masses.

Per Hellman1, Ola Hessman, Göran Akerström, Peter Stålberg, Joakim Hennings, Martin Björck, L-G Eriksson.   

Abstract

BACKGROUND: Midgut carcinoid (MGC) tumors generally develop in the small intestine and in >50% of cases also present with lymph node metastases in the mesentery. The majority of these tumors are surgically resectable, but a fraction are inoperable and may cause obstruction of the superior mesenteric vein (SMV), often associated with stasis of the intestinal wall and severe symptoms. These symptoms include severe abdominal pain, attacks of diarrhea, and malnutrition.
METHODS: Seven patients with severe MGC including a large fibrotic inoperable mesenteric mass and severe symptoms were studied. After an obstructed SMV and signs of venous stasis in the small intestine were demonstrated, an expandable stent was inserted after puncturing an intrahepatic portal venous branch. The associated venography, patient symptoms, and radiological signs on computed tomography (CT) scans were evaluated.
RESULTS: Four patients demonstrated resolution of their symptoms. In one patient who had intra-abdominal lymph leakage/chyloperitoneum, a complete normalization of the circulation followed and the intra-abdominal lymph leakage stalled. The venographies demonstrated normalization of the venous blood flow through the SMV, and CT scans demonstrated reduction in the thickness of the intestinal wall. In two cases there were no changes in the symptoms, and in one case a slight worsening of the symptoms ensued. In general, reductions of symptoms were associated with the degree of normalization of venous blood flow.
CONCLUSIONS: We conclude that in selected patients with MGC stenting of the SMV may improve symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20066417     DOI: 10.1007/s00268-009-0361-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated jejunal-ileal tumor/carcinoma.

Authors:  Barbro Eriksson; Günter Klöppel; Eric Krenning; Hakan Ahlman; Ursula Plöckinger; Bertram Wiedenmann; Rudolf Arnold; Christoph Auernhammer; Meike Körner; Guido Rindi; Stefan Wildi
Journal:  Neuroendocrinology       Date:  2007-12-12       Impact factor: 4.914

2.  Post-traumatic superior mesenteric arteriovenous fistula: endovascular treatment with a covered stent.

Authors:  Chun-Gen Wu; Yong-Dong Li; Ming-Hua Li
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

3.  Variceal hemorrhage associated with portal vein thrombosis: treatment with a unique portal venous stent.

Authors:  L E Harville; F J Rivera; J C Palmaz; B A Levine
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

4.  Extrahepatic portal venous stenosis: treatment with percutaneous transhepatic stent placement.

Authors:  R L Vogelzang; S G Reddy; M A Braun; A A Nemcek
Journal:  J Vasc Interv Radiol       Date:  1996 Mar-Apr       Impact factor: 3.464

Review 5.  Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.

Authors:  Jeffrey A Norton
Journal:  Best Pract Res Clin Gastroenterol       Date:  2005-08       Impact factor: 3.043

6.  Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein.

Authors:  K Yamakado; N Tanaka; A Nakatsuka; K Matsumura; K Takase; K Takeda
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

7.  Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors.

Authors:  C Makridis; J Rastad; K Oberg; G Akerström
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

Review 8.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

9.  Pancreas transplant venous thrombosis: role of endovascular interventions for graft salvage.

Authors:  Andrew H Stockland; Darrin L Willingham; Ricardo Paz-Fumagalli; Hani P Grewal; J Mark McKinney; Christopher B Hughes; Eric M Walser
Journal:  Cardiovasc Intervent Radiol       Date:  2009-01-30       Impact factor: 2.740

10.  Percutaneous transhepatic stenting by Wallstents of portal vein and bile duct stenoses caused by immunoblastic sarcoma in a liver transplantation.

Authors:  J I Bilbao; M Ruza; J M Longo; F Mansilla; A Picardi; V de Villa; F Pardo; J Sola; J Quiroga
Journal:  Cardiovasc Intervent Radiol       Date:  1994 Jul-Aug       Impact factor: 2.740

View more
  8 in total

1.  Partial abdominal evisceration and intestinal autotransplantation to resect a mesenteric carcinoid tumor.

Authors:  William H Kitchens; Nahel Elias; Lawrence S Blaszkowsky; A Benedict Cosimi; Martin Hertl
Journal:  World J Surg Oncol       Date:  2011-01-31       Impact factor: 2.754

2.  Management of Locally Advanced and Unresectable Small Bowel Neuroendocrine Tumours.

Authors:  Jonathan Koea
Journal:  World J Surg       Date:  2020-08-28       Impact factor: 3.352

3.  Percutaneous Transhepatic Approach for Recanalization of Superior Mesenteric and Portal Vein in a Patient With Pancreatic Neuroendocrine Tumor Presenting With Bleeding Duodenal Varices: A Brief Case Report.

Authors:  Ajit Yadav; Gaurav Gangwani; Nitin Mishra; Arun Gupta
Journal:  J Clin Exp Hepatol       Date:  2018-03-30

Review 4.  How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?

Authors:  Bruno Niederle; Andreas Selberherr; Martin B Niederle
Journal:  Curr Oncol Rep       Date:  2021-05-20       Impact factor: 5.075

5.  Percutaneous transhepatic placement of a stent-graft to treat a delayed mesoportal hemorrhage after pancreaticoduodenectomy.

Authors:  Michael Ginsburg; Hector Ferral; Marc J Alonzo; Mark S Talamonti
Journal:  World J Surg Oncol       Date:  2014-10-15       Impact factor: 2.754

6.  Neoadjuvant peptide receptor radionuclide therapy and modified multivisceral transplantation for an advanced small intestinal neuroendocrine neoplasm: an updated case report.

Authors:  Ashley K Clift; Henk Giele; Srikanth Reddy; Rubens Macedo; Adil Al-Nahhas; Harpreet S Wasan; Gabriel E Gondolesi; Rodrigo M Vianna; Peter Friend; Anil Vaidya; Andrea Frilling
Journal:  Innov Surg Sci       Date:  2017-08-25

7.  Percutaneous transhepatic stent for chronic intestinal bleeding from jejunal varices in primary idiophatic superior mesenteric vein stenosis: A case report.

Authors:  Renato Argirò; Leonardo Vattermoli; Francesca Di Pietro; Sara Crociati; Luca Funari; Valentina Perlangeli; Roberto Floris
Journal:  Radiol Case Rep       Date:  2022-02-12

8.  Mesenteric changes in an ultrasound examination can facilitate the diagnosis of neuroendocrine tumors of the small intestine.

Authors:  Andrzej Smereczyński; Teresa Starzyńska; Katarzyna Kołaczyk
Journal:  J Ultrason       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.